Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Bottneuro AG logo — Precision medicine for brain health

Bottneuro AG

Precision medicine for brain health

Founded 2021 Switzerland Switzerland 12 employees Convertible Note Total: $4.15M Health Care, Health and Wellness

General Information

Company Name Bottneuro AG
Founded Year 2021
Location Switzerland Switzerland +3
Founders / Decision Makers
Team member
Employees 12
Industries Health Care, Health and Wellness
Funding Stage Convertible Note
Social

Get notified when Bottneuro AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bottneuro AG

Bottneuro AG is a Switzerland-based health care startup founded in 2021. The company is focused on developing non-invasive custom-made tCS/EEG devices for the diagnosis and treatment of neurological diseases. Emphasizing precision medicine for brain health, Bottneuro's innovative approach involves capturing brainwave patterns for early intervention and conducting multifocal electrical stimulation sessions of specific brain regions through personalized, 3D-printed, wearable headsets. The company's solution integrates both software and hardware components, including a tablet and a neckpiece housing the electronics and in-house developed brush electrodes, eliminating the need for shaving. Notably, electrode placement is calculated based on MRI scans of the patient's head to stimulate only the disease-affected regions, with the 3D-printed cap ensuring repeated and precise electrode positioning for each stimulation session. In December 2022, Bottneuro received a significant Fr.4.00M investment through a Convertible Note from Zühlke Ventures AG, Hemex, and DART Ventures. This funding is expected to further support the company's development of innovative solutions in the field of precision medicine for brain health.

Taxonomy: neurological diseases, diagnosis, treatment, brainwave patterns, multifocal electrical stimulation, wearable headsets, 3D-printed technology, MRI scans, electrode placement, personalized treatment, non-invasive, brain health, neuroscience

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 3
Investor Investor
•••• •••• 		15 Dec 2022
Grant •••••• 1 •••• •••• 12 Dec 2022
Grant •••••• 1
Investor
17 Dec 2021

Bottneuro AG Alternatives & Competitors

Bottneuro AG vs
Greenbrook
Greenbrook United States

Greenbrook is a leading provider of TMS therapy & Spravato® nasal esketamine treatment for depressio...

Post Ipo Equity
357 employees
Health Care
Bottneuro AG vs
Hedera Dx
Hedera Dx Switzerland

Modern cancer care to the next billion people

Series A
31 employees
Health Care
Bottneuro AG vs
Sooma Medical
Sooma Medical Finland

Depression treatment at home. Transforming psychiatric and neurological care with accessible therapi...

Unknown
22 employees

FAQ About Bottneuro AG

Precision medicine for brain health
Bottneuro AG was founded in 2021.
Bottneuro AG is headquartered in Switzerland.
Bottneuro AG operates in the following industries: Health Care, Health and Wellness.
Bottneuro AG has approximately 12 employees.
Bottneuro AG has completed 3 funding rounds, raising a total of $4.15M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Bottneuro AG include Greenbrook, Hedera Dx, Sooma Medical, IKOMED Technologies Inc., Taryag Medical . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bottneuro AG and Greenbrook are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bottneuro AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy